We used a tumor microarray (TMA) including >600 clinically annotated CRC to address the prognostic significance of CRC infiltration by OX40+ cells, as evaluated in combination with CD8+ and FOXP3+ cell infiltration. This evidence concerns the gene CD8A and neoplasm.